Monday, 11 Nov 2019

You are here

Dr. Deodhar: tofacitinib, secukinumab and the treatment of ankylosing spondylitis

Dr. Atul Deodhar, a rheumatologist at Oregon Health & Science University in Portland, Oregon, discusses two late-breaking abstracts (5L and 6L) regarding the treatment of ankylosing spondylitis.

Add new comment

Want to talk about this video? Comment here to lead the discussion.
MORE VIDEOS

Dr. Peter Lipsky - 1 Million #Gout...

21 Jun 2019

Dr. Jack Cush: Update on vaccinations...

02 Mar 2016

Dr. Nicole Bitencourt: Summer Camps for...

22 Oct 2018

RheumNow Week in Review – 30 September...

30 Sep 2016

Dr. Elaine Alexander: Kikuchi-Fujimoto...

09 Feb 2018

Dr. Tajvur Saber: Why RheumNow is...

14 Nov 2016

The RheumNow Week in Review - 16 March...

16 Mar 2018

Dr. Julio Gonzalez: Spondyloarthritis

23 Oct 2018

RheumNow Podcast – A Grand New Year (1....

04 Jan 2019

Dr. Gerd Burmester reviews the SEMIRA...

21 Jun 2019

Dr. Rachel T. Huston: Drug Exposure in...

01 Dec 2016

RheumNow Week in Review – 2 September...

02 Sep 2016